Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last hours
Enjoy this offer
* See conditions under "Our services"

Valuation: Vitrolife AB

Market Cap 12.33B 1.29B 1.12B 1.04B 973M 1.82B 121B 1.84B 4.78B 59.78B 4.83B 4.73B 208B P/E 2026 *
25.1x
P/E 2027 * 20.2x
Enterprise Value 12.66B 1.32B 1.15B 1.07B 999M 1.87B 125B 1.88B 4.91B 61.38B 4.96B 4.85B 213B EV / Sales 2026 *
3.61x
EV / Sales 2027 * 3.21x
Free-Float
54.39%
Yield 2026 *
1.17%
Yield 2027 * 1%
1 day-1.67%
1 week-4.91%
Current month-7.94%
1 month-15.69%
3 months+3.52%
6 months-31.39%
Current year-33.54%
1 week 90.6
Extreme 90.6
97.95
1 month 90.6
Extreme 90.6
109.5
Current year 84.6
Extreme 84.6
139.6
1 year 84.6
Extreme 84.6
153.5
3 years 84.6
Extreme 84.6
268
5 years 84.6
Extreme 84.6
585
10 years 70
Extreme 70
585
Manager TitleAgeSince
Chief Executive Officer 52 2023-07-31
Director of Finance/CFO 55 2025-10-09
Chief Investment Officer 39 -
Director TitleAgeSince
Director/Board Member 63 2013-04-18
Chairman 70 2023-07-31
Chairman 55 -
Date Insider Type Main position Quantity % Market Cap.
02-05Buy

Chief Operating Officer

6,470 0.0048%
02-05Buy

Chief Executive Officer

3,013 0.0022%
02-03Buy

Chief Financial Officer

2,200 0.0016%
Change 5-day change 1-year change 3-year change Capi.($)
-1.67%-4.91%-33.54%-58.42% 1.29B
+2.07%+0.12%+168.17%+253.96% 17.47B
+2.15%+1.85%-42.64%-22.56% 9.33B
+0.65%-0.63%+31.15%+11.83% 6.76B
+3.42%+2.78%-32.22% - 5.22B
-1.64%-3.63%-27.65%-32.78% 4.88B
+10.00%+20.71%+105.80%+104.59% 4.54B
+8.17%+20.51%+221.51%-39.98% 4.41B
+2.07%-2.17%-31.05%-33.48% 3.95B
-1.74%-2.46%-17.42%-43.06% 2.57B
Average +2.35%+3.14%+34.21%+15.57% 6.04B
Weighted average by Cap. +2.54%+2.99%+61.14%+74.75%

Financials

2026 *2027 *
Net sales 3.5B 366M 319M 295M 277M 519M 34.52B 522M 1.36B 16.99B 1.37B 1.34B 59B 3.77B 394M 344M 318M 298M 559M 37.18B 562M 1.46B 18.3B 1.48B 1.45B 63.54B
Net income 491M 51.28M 44.71M 41.41M 38.77M 72.7M 4.84B 73.14M 190M 2.38B 192M 188M 8.27B 610M 63.65M 55.49M 51.39M 48.11M 90.23M 6.01B 90.78M 236M 2.96B 239M 234M 10.26B
Net Debt 330M 34.41M 30M 27.78M 26.01M 48.78M 3.25B 49.07M 128M 1.6B 129M 126M 5.55B -222M -23.15M -20.19M -18.69M -17.5M -32.82M -2.18B -33.02M -85.95M -1.08B -86.9M -85.04M -3.73B
Logo Vitrolife AB
Vitrolife AB is a Sweden-based company engaged in assisted reproduction services. The Company’s product portfolio comprises G-RINSE, which is a solution for rinsing of contact materials, EmbryoGlue, which is a human albumin recombinant, ASP, which is a solution for oocyte retrieval and rinsing, and Semen VTS, which is a viscosity treatment system, among others. It also provides a range of procedural solutions for sperm preparation, vitrification, embryo transfer and oocyte retrieval, such as temperature control, condition control, gamete-safe labware and embryo support. The Company is active in Australia, China, France, Italy, Japan, the United States and the United Kingdom, among others, and conducts its business through a number of subsidiaries, such as Vitrolife Ltd., Vitrolife Pty Ltd., and A.T.S. Srl.
Employees
1,126
Date Price Change Volume
26-06-18 91.05 kr -1.67% 208,501
26-06-17 92.60 kr +0.76% 168,304
26-06-16 91.90 kr -4.17% 174,521
26-06-15 95.90 kr +0.16% 185,116
26-06-12 95.75 kr -0.47% 745,674
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
91.05SEK
Average target price
162.75SEK
Spread / Average Target
+78.75%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. VITR Stock
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!